Sonnet BioTherapeutics Holdings, Inc. earnings per share and revenue

SONN earnings per share for the last quarter are -3.83 USD whereas the estimation was -5.52 USD which accounts for 30.62% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 0.00 USD. Estimated earnings per share for the next quarter are -1.39 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of SONN earnings per share and revenue dynamics.